Hint mode is switched on Switch off

LABU - Direxion Daily S&P Biotech Bull 3X Shares (USD) (US25460G1206)

The comparsion limit has been reached: only 5 tools has been added. To add a new one, please remove one of the existing tools.

FIND, SAVE & TRACK INVESTMENTS WITH CBONDS WATCHLIST

With Cbonds Watchlist you can always stay updated on your investments to make conscious decisions!

Watchlist
You need to request access
Cbonds API
Bring Market Data into Your Systems

Access ETF and Mutual Funds Data via API

  • Prices & NAV
  • Fund Structure
  • Inflows & dividends

Leveraged

 
(%)
US25460G1206
LABU ISIN
Exchange Traded Funds (ETF)
Type of fund
Direxion Funds
Provider
242.24 USD
NAV per Share | 27/10/2026
28/05/2015
Inception Date
4 times per year
Dividend payments
CEOILS
CFI
LABU
Ticker
Formed
Status
Equity
Investment category
Biotech
Sector
USA
Investor locations
The S&P Biotechnology Select Industry Index
Benchmark
0.93 %
Total Cost Ratio
635.76 mln USD
Fund NAV | 27/10/2026
635.76 mln USD
Share Class NAV | 27/10/2026
No
UCITS
20 / 1 (02/12/2023)
Split

Try in 7-days Trial access

  • Get full online access to the database
  • Use our powerful bond screener
  • Track bond prices from 400+ sources
  • Smart Portfolio Monitoring

Yield on 27/10/2026, NYSE Arca

  • YTD
    53.81 %
  • 1M
    -4.05 %
  • 3M
    -1.63 %
  • 6M
    30.73 %
  • 1Y
    91.25 %
  • 3Y
    397.36 %
  • 5Y
    -75.46 %
  • 10Y
    -59.71 %
At the price on the exchange, taking into account income payments

Latest data on
Add to compare

Quotes (LABU)

Explore the most comprehensive database

1 000 000

bonds

100 000

stocks

175 910

ETF & Funds

100 000

indices

Track your portfolio in the most efficient way

  • Bond Search
  • Watchlist
  • Excel ADD-IN
×

— Are you looking for the complete & verified bond data?

— We have everything you need:

full data on over 1 000 000 bonds, 100 000 stocks, 100 000 indices, 17 000 ETF and 150 000 Mutual Funds; powerful bond screener; over 350 pricing sources among stock exchanges & OTC market; ratings & financial reports; user-friendly interface; available anywhere via Website, Excel Add-in and Mobile app.

Register
×

Why

You will have detailed descriptive & pricing data for 1M bonds, 100K stocks, 100K indices, 17K ETF and 150K Mutual Funds
Get full access to the platform from any device & via Cbonds app
Enhance your portfolio management with Cbonds Excel Add-in
Build yield maps, make chart comparison within a click
Don't wait any longer — start using Cbonds today! Register

Price dynamics

LABU profile

The Direxion Daily S&P Biotech Bull 3X Shares (USD) is a(n) Equity Exchange Traded Funds (ETF) seeks to invest in Biotech sector located in USA. The Direxion Funds fund’s base currency is USD and the share class was registered 28.05.2015 with unique ISIN - US25460G1206. Main exchange is NYSE Arca and ticker symbol is LABU. The total expense ratio is 0.93%. The Direxion Daily S&P Biotech Bull 3X Shares (USD) pays dividends 4 time(s) per year.

Structure LABU on 28/10/2026

Paper Value
SPSIBI SWAP ASSET LEG 53.4%
SPSIBI SWAP ASSET LEG 49.02%
SPSIBI SWAP ASSET LEG 44.64%
SPSIBI SWAP ASSET LEG 35.45%
SPSIBI SWAP ASSET LEG 30.05%
SPSIBI SWAP ASSET LEG 15.23%
GOLDMAN FINL SQ TRSRY INST 506 14.17%
DREYFUS GOVT CASH MAN INS 13.81%
SPSIBI SWAP ASSET LEG 2.65%
MODERNA INC 1.56%
TWIST BIOSCIENCE CORP 1.3%
NATERA INC 1.27%
BIOGEN INC 1.22%
HALOZYME THERAPEUTICS INC 1.22%
UNITED THERAPEUTICS CORP 1.19%
AMGEN INC 1.17%
ABBVIE INC 1.16%
SPYRE THERAPEUTICS INC 1.16%
EXELIXIS INC 1.14%
IOVANCE BIOTHERAPEUTICS INC 1.13%
GILEAD SCIENCES INC 1.11%
ORUKA THERAPEUTICS INC 1.07%
TG THERAPEUTICS INC 1.05%
REGENERON PHARMACEUTICALS 1.03%
GRAIL INC 1.02%
VERTEX PHARMACEUTICALS INC 1.02%
ALKERMES PLC 0.99%
PROTAGONIST THERAPEUTICS INC 0.99%
CRISPR THERAPEUTICS AG 0.96%
NEUROCRINE BIOSCIENCES INC 0.96%
INCYTE CORP 0.94%
KRYSTAL BIOTECH INC 0.94%
PTC THERAPEUTICS INC 0.94%
BRIDGEBIO PHARMA INC 0.93%
REVOLUTION MEDICINES INC 0.91%
ALNYLAM PHARMACEUTICALS INC 0.89%
ROIVANT SCIENCES LTD 0.89%
ERASCA INC 0.88%
BIOMARIN PHARMACEUTICAL INC 0.87%
KYMERA THERAPEUTICS INC 0.87%
COGENT BIOSCIENCES INC 0.86%
CYTOKINETICS INC 0.84%
VAXCYTE INC 0.83%
MADRIGAL PHARMACEUTICALS INC 0.82%
KODIAK SCIENCES INC 0.81%
VERACYTE INC 0.81%
IONIS PHARMACEUTICALS INC 0.8%
PRAXIS PRECISION MEDICINES I 0.79%
TRAVERE THERAPEUTICS INC 0.78%
DIANTHUS THERAPEUTICS INC 0.76%
RHYTHM PHARMACEUTICALS INC 0.75%
INSMED INC 0.75%
ARROWHEAD PHARMACEUTICALS IN 0.73%
MIRUM PHARMACEUTICALS INC 0.72%
IMMUNITYBIO INC 0.7%
CG ONCOLOGY INC 0.67%
ARCUTIS BIOTHERAPEUTICS INC 0.66%
CAREDX INC 0.64%
TANGO THERAPEUTICS INC 0.64%
RELAY THERAPEUTICS INC 0.63%
VIKING THERAPEUTICS INC 0.59%
ULTRAGENYX PHARMACEUTICAL IN 0.59%
BEAM THERAPEUTICS INC 0.59%
CELCUITY INC 0.56%
SCHOLAR ROCK HOLDING CORP 0.53%
DYNE THERAPEUTICS INC 0.51%
SELLAS LIFE SCIENCES GROUP I 0.48%
RECURSION PHARMACEUTICALS-A 0.47%
AGIOS PHARMACEUTICALS INC 0.45%
IMMUNOVANT INC 0.42%
VIRIDIAN THERAPEUTICS INC 0.42%
HYPERLIQUID STRATEGIES 0.41%
DENALI THERAPEUTICS INC 0.41%
NURIX THERAPEUTICS INC 0.4%
DISC MEDICINE INC 0.4%
BIOHAVEN LTD 0.39%
SAREPTA THERAPEUTICS INC 0.39%
BIOCRYST PHARMACEUTICALS INC 0.39%
SUMMIT THERAPEUTICS INC 0.39%
VERA THERAPEUTICS INC 0.38%
IDEAYA BIOSCIENCES INC 0.37%
INTELLIA THERAPEUTICS INC 0.36%
ABSCI CORP 0.36%
ADMA BIOLOGICS INC 0.35%
ACADIA PHARMACEUTICALS INC 0.34%
UNIQURE NV 0.34%
CELLDEX THERAPEUTICS INC 0.33%
PALVELLA THERAPEUTICS INC 0.33%
VERICEL CORP 0.33%
NOVAVAX INC 0.32%
GOLDMAN SACHS FIN GOV 465 INSTITUT 0.29%
FIRST TRACKS BIOTHERAPEUTICS 0.27%
XENCOR INC 0.27%
ARCUS BIOSCIENCES INC 0.26%
NEKTAR THERAPEUTICS 0.26%
IMMUNOME INC 0.25%
PRECIGEN INC 0.24%
SYNDAX PHARMACEUTICALS INC 0.24%
STOKE THERAPEUTICS INC 0.24%
REPLIMUNE GROUP INC 0.22%
Other - %
Welcome to Cbonds
New to Cbonds? · Take a 90-second tour of the platform.

Discover what you can do with Cbonds

Everything you need for fixed income research and monitoring.

  • 00:23 Coverage
  • 00:40 Bond screener
  • 00:54 Parameters
  • 01:10 Watchlist, Mobile app
  • 01:15 Excel Add-in

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Other ETF & Funds from this provider

Similar ETF & Funds

  • {{ item.etf.ttl }}
    {{ item.nav_usd }} mln
    NAV
    {{ item.expense_ratio }}
    Total Cost Ratio
Registration is required to get access.